Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Watch on Radcliffe Cardiology:

Dr James Ip (Weill Cornell Medical College, New York, NY, US) joins us in a short interview from HRS 2022 to discuss the long-term findings from the NODE-302 study. This trial aimed to evaluate the effectiveness and safety of self-administered etripamil nasal spray in patients with an episode of paroxysmal supraventricular tachycardia in an outpatient setting.

Discussion points:
1. Aims of the NODE-302 study
2. Patient population and study design
3. Key findings
4. Take-home messages
5. Further research needed and next steps

Recorded onsite at HRS 2022, San Francisco.

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Чтобы скачать видео "HRS 22: Long-Term Outcomes of the NODE-302 Study | Dr James Ip" передвинте ползунок вправо